(Z)-ethyl 2-ethoxy-1-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate; ethyl (Z)-2-ethoxy-1-((2'-(N'-((ethoxycarbonyl)oxy)carbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate
Azilsartan Ethyl Ring-opening Impurity is a fully characterized chemical compound used as a reference standard of API Azilsartan. The standard offered is compliant with regulatory guidelines. Azilsartan Ethyl Ring-opening Impurity is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1403474-75-8
Related products
Azilsartan Imidazole Carbonyl Dioxolene Ester
M.F. C₃₃H₂₈N₆O₈
M.W. 636.62
CAT# AR-A04723
CAS# 1514933-19-7
Azilsartan Medoxomil Potassium Salt
M.F. C₃₀H₂₃N₄O₈; K
M.W. 567.53; 39.10
CAT# AR-A05151
CAS# 863031-24-7